Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections

NCT04708171 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04708171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2022
Completion date
October 1, 2026
Enrollment
453 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma